The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Cutaneous Oncology: A Systematic Review of Evidence beyond Malignant Melanoma

K Seretis, K Sfaelos, E Boptsi, G Gaitanis, ID Bassukas - Cancers, 2024 - mdpi.com
Simple Summary This systematic review concludes that a higher neutrophil-to-lymphocyte
ratio (NLR), a robust indicator of adverse prognosis across the common metastatic cancers …

Significance of CD103+ tissue-resident memory T cells for predicting the effectiveness of immune checkpoint inhibitors in esophageal cancer

S Natsuki, H Tanaka, M Nishiyama, S Deguchi, Y Miki… - BMC cancer, 2023 - Springer
Abstract Background Immune checkpoint inhibitors (ICIs), including nivolumab, have been
approved to treat esophageal cancer. However, these remedies are not fit for all patients …

Prognostic factors for esophageal squamous cell carcinoma without pathological lymph node metastasis after neoadjuvant therapy and surgery

Y Hamai, M Emi, Y Ibuki, Y Murakami… - World Journal of …, 2024 - Wiley Online Library
Background Pathological lymph node metastasis (LNM) following multimodal therapy is an
important indicator of poor prognosis in patients with esophageal cancer. However, a …

Inflammatory biomarkers as predictors of immune activation to different irradiated sites and short-term efficacy in advanced squamous cell esophageal carcinoma …

M Li, G Cai, Z Gao, X Meng, X Han - Frontiers in Oncology, 2023 - frontiersin.org
Purpose The present study aimed to compare immune activation among different irradiated
sites and identify potential short-term efficacy prognostic factors in patients with advanced …